# An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia

> **NCT01105793** · PHASE2 · COMPLETED · sponsor: **FemmePharma Global Healthcare, Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Moderate to Severe Cyclic Mastalgia

## Interventions

- **DRUG:** Danazol

## Key facts

- **NCT ID:** NCT01105793
- **Lead sponsor:** FemmePharma Global Healthcare, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01105793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01105793, "An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01105793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*